Essa M. Saied | Pharmaceutical Sciences | Research Excellence Award

Published on by Network Science

Dr. Essa M. Saied | Pharmaceutical Sciences | Research Excellence Award

Humboldt University of Berlin | Germany

Dr. Essa M. Saied is a distinguished Senior Researcher in the Bioorganic Chemistry Department at Humboldt University of Berlin, Germany, and an Associate Professor of Biochemistry in the Chemistry Department at Suez Canal University, Egypt. His research spans the fields of bioorganic and biochemistry with strong expertise in synthetic medicinal chemistry, heterocyclic chemistry, small-molecule drug discovery, high-throughput screening, molecular modelling, virtual screening, enzymatic assays, anticancer research, and lipid chemistry in human diseases. He earned his Ph.D. in Organic and Bioorganic Chemistry from Humboldt-Universität zu Berlin in 2017 with a thesis on “Synthesis and Characterization of Inhibitors of Sphingolipid Metabolism,” following a Master of Science in Organic Chemistry from Suez Canal University with an excellent grade and earlier pre-master coursework in Organic, Physical, and Inorganic Chemistry. Dr. Saied has secured several competitive grants and fellowships, including the Yousef Jameel Ph.D. Fellowship, the EXIST-Gründerstipendium for the “Lipotools – Lipids in Focus of Pharmacological Drug Development” startup, the Royal Chemical Society Researcher Development Grant, and funding from the Deanship for Research & Innovation, Ministry of Education in Saudi Arabia. His professional experience reflects a strong international footprint, serving as a senior researcher in Berlin since 2017, a visiting scientist at Children’s Cancer Hospital Egypt (57357), and a former CEO of the “Lipotools” startup, alongside progressive academic roles in Suez Canal University. His major scientific interests include drug synthesis and development, small-molecule screening, computer-aided drug design, development of biochemical and enzymatic tools, lipid-based disease research, and drug repurposing to treat human diseases.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Dyslipidemic SPTLC3 Integrates Bile Acid-FXR Signaling with Sphingolipid Remodeling in MASLD", M Visentin, Z Gai, A Kovilakath, F De Luca, G Panteloglou, A Othman, bioRxiv, 2025.

"Editorial on research topic Medicinal Chemistry for Neglected Tropical Diseases Using In-vitro, In-vivo and In Silico Approaches", SN Mali, EM Saied, CBR Dos Santos, J Neves Cruz, Frontiers in Chemistry 13, 2025.

"Integrative Metabolomic, Network Pharmacology, and Experimental Evidence for Lepidium sativum Seed Extract as a Natural Modulator of Pulmonary Fibrosis via the ncNRFR/Let-7d", IM Alanazi, HH Abo Nahas, DI Mohamed, N Hosny, YHA Elewa, Pharmaceuticals 18 (12), 2025.

"Multi-targeted azacoumarin–cyanocinnamate hybrids induce G 2/M arrest and apoptosis via tubulin, and COX-2/VEGFR modulation: insights from in vitro mechanistic basis", MA El-Zend, IM El-Deen, RM Mansour, TA Yousef, AA Alrashidi, RSC Medicinal Chemistry, 2025.

"Exploration of the anticancer efficacy of a novel 1, 3-thiazole analog in an ehrlich ascites carcinoma model: in vivo and in silico insights into hepatorenal protective", M El Behery, DM Abo-Elmatty, M Alsunbul, YIM El-Deen, DI Mohamed, RSC advances 15 (25), 2025.

Raquel Martín García | Biological Network | Best Research Article Award

Published on by Network Science

Dr. Raquel Martín García | Biological Network | Best Research Article Award

Puerta de Hierro University Hospital Majadahonda | Spain

Dr. Raquel Martín García is a highly accomplished neurologist specializing in movement and sleep disorders, with extensive academic and clinical expertise. She earned her Degree in Medicine and Surgery (2010–2016) and is currently pursuing her Doctorate in Medicine and Surgery at the Autonomous University of Madrid. After completing her Neurology specialization at Puerta de Hierro University Hospital (2017–2021), she has since served as a Specialist Physician in the Movement Disorders Unit and the Sleep Unit at leading hospitals and research centers in Madrid, including the Sleep Research Institute and CISNe Comprehensive Sleep and Neuroscience Center. Dr. Martín García holds multiple postgraduate qualifications, including a Master’s in Movement Disorders, expert titles in Headaches and Neurosonology, and advanced certifications in cerebrovascular and hereditary neurological diseases. Her research contributions include several publications in prestigious international journals such as European Journal of Neurology, Brain Sciences, and Epilepsy & Behavior, as well as book chapters for Springer and the Oxford Handbook of Sleep and Sleep Disorders. She has actively presented her work at major neurology conferences, participated as a sub-investigator in numerous Phase II and III clinical trials on Parkinson’s disease and multiple sclerosis, and contributed to teaching and mentoring at the Autonomous University of Madrid. Recognized for her dedication to advancing neurological sciences, she received the STADA Fellowship from the AMN Movement Disorders Group in 2024.

Profiles: Scopus

Featured Publications

"Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study", Martín García R, Plos One, 2025.

Kumail Abbas | Technological Networks | Best Researcher Award

Published on by Network Science

Dr. Kumail Abbas | Technological Networks | Best Researcher Award

Chulalongkorn University | Thailand

Dr. Kumail Abbas is a veterinary scientist and researcher specializing in precision livestock farming, animal health, and welfare technologies. He is currently pursuing his Doctor of Philosophy in Veterinary Science and Technology at Chulalongkorn University, Thailand, where his doctoral research focuses on employing artificial intelligence to track and monitor dairy cow behaviour during the transition period to predict postpartum disorders. As a Visiting Researcher at the Bristol Vet School, University of Bristol, and University of Salford (UK), Dr. Abbas contributes to the British Dairy Cattle Welfare Strategy (2023–2028) through AI-based behavioural monitoring and data-driven welfare benchmarking. He holds a Master’s in Bioscience Technology from Chung Yuan Christian University, Taiwan, where he investigated the neurophysiological and toxicological effects of ractopamine in zebrafish models, and a Doctor of Veterinary Medicine (DVM) from the University of Veterinary and Animal Sciences, Lahore, Pakistan. His professional experience spans academia, industry, and farm management, including roles as Graduate Research Assistant at Chung Yuan Christian University, Product Information Officer at Prix Pharmaceutica (Pvt.) Ltd., and Assistant Farm Manager at Kasur Dairies Pvt. Ltd., where he developed strong expertise in animal reproduction, health management, and sustainable dairy operations. Dr. Abbas’s research integrates AI, deep learning, and animal behaviour analysis to promote sustainable livestock production. He has received multiple awards and grants, including the Second Century Fund (C2F) Doctoral Fellowship, the 90th Anniversary Ratchadaphisek Somphot Endowment Fund, and the Biotech Excellent Award for academic excellence. His work has been published in international journals and presented at global conferences, reflecting his commitment to advancing innovation in animal science, digital agriculture, and welfare-oriented livestock technologies.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

"Impacts of early postpartum behavioral patterns on the fertility and milk production of tropical dairy cows"

"Behavioral Adaptations in Tropical Dairy Cows: Insights into Calving Day Predictions"

"Ractopamine at the Center of Decades-Long Scientific and Legal Disputes: A Lesson on Benefits, Safety Issues, and Conflicts"

"Evaluation of Effects of Ractopamine on Cardiovascular, Respiratory, and Locomotory Physiology in Animal Model Zebrafish Larvae"

"Sex determination by CHD (Chromo helicase DNA binding) gene in local rock pigeons (Columba livia) from Lahore, Pakistan"

Cora Sternberg | Meta analysis | Outstanding Scientist Award

Published on by Network Science

Dr. Cora Sternberg | Meta analysis | Outstanding Scientist Award

Weill Cornell Medicine | United States

Author Profiles

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Dr. Cora Sternberg’s academic journey reflects her commitment to excellence from the outset. She completed her medical training with distinction and pursued advanced fellowships, including a Research Fellowship in Immunology at the National Institutes of Health (1976–1977). Her early academic roles as Teaching Assistant at Stanford and Mount Sinai, followed by Clinical Instructor at Cornell University, laid the foundation for her lifelong dedication to education and clinical research. Her Phi Beta Kappa distinction from the University of Pennsylvania marked the start of a career dedicated to innovation and leadership in oncology.

Professional Endeavors

Over four decades, Dr. Sternberg has held prestigious academic and clinical leadership roles. She was Chief of Medical Oncology at San Camillo-Forlanini Hospital in Rome and served as Professor at La Sapienza University, shaping Italy’s oncology community. Since 2018, she has been Professor of Medicine and Clinical Director of the Englander Institute for Precision Medicine at Weill Cornell Medicine and New York-Presbyterian. She has also served as a global faculty member at Temple University, Tufts University, and European institutions.

Contributions and Research Focus

Dr. Sternberg has pioneered groundbreaking research in prostate cancer, bladder cancer, and renal cell carcinoma. She was instrumental in developing practice-changing therapies such as abiraterone, enzalutamide, and darolutamide, significantly improving survival outcomes for prostate cancer patients. Her work in urothelial cancer led to the establishment of M-VAC chemotherapy and global adoption of immunotherapy protocols. She also contributed to the development of pazopanib and other targeted therapies in renal cell carcinoma. Recently, she has expanded her research focus to artificial intelligence in oncology, spearheading initiatives to integrate AI into therapeutic decision-making.

Impact and Influence

With over 546 publications, six textbooks, and more than 45,200 citations, Dr. Sternberg ranks among the World’s Top 2% Scientists (Stanford University) and the top 5% in the Doximity community for citations. She has delivered more than 835 lectures worldwide, influencing clinical practice, policy, and guidelines in oncology. Her leadership roles in international organizations such as ASCO, ESMO, ECCO, and EORTC demonstrate her far-reaching influence.

Academic Citations

Dr. Sternberg’s research impact is widely recognized. Her publications in high-impact journals such as New England Journal of Medicine, Lancet Oncology, and Journal of Clinical Oncology have shaped global treatment standards. Her works are consistently cited in clinical guidelines, trial protocols, and oncology education, affirming her stature as a thought leader in medical oncology.

Legacy and Future Contributions

Dr. Sternberg’s legacy lies not only in transformative research but also in mentorship. She has nurtured generations of oncologists, fostering innovation and translational research. Currently, she co-leads the Career Development Program in the Bladder SPORE initiative, ensuring the pipeline of future oncology leaders. Her pioneering role in AI in oncology positions her to continue shaping the future of precision medicine, bridging clinical care with technological innovation.

Conclusion

Dr. Cora Sternberg exemplifies the qualities of an Outstanding Scientist—visionary leadership, transformative research, global influence, and unwavering dedication to advancing oncology. Her lifelong contributions to clinical practice, groundbreaking research, academic mentorship, and adoption of emerging technologies ensure her lasting impact on the medical community and future generations of scientists.

Notable Publications

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100" 

  • Author: homas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Cancers
  • Year: 2025

"The Use of Artificial Intelligence for Cancer Therapeutic Decision-Making" 

  • Author: Olivier Elemento; Sean Khozin; Cora N. Sternberg
  • Journal: NEJM AI
  • Year: 2025

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100" 

  • Author: Thomas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Preprint
  • Year: 2025

"Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591" 

  • Author: Scott T. Tagawa; Charlene Thomas; A. Oliver Sartor; Michael Sun; Judith Stangl-Kremser; Mahelia Bissassar; Shankar Vallabhajosula; Sandra Huicochea Castellanos; Jones T. Nauseef; Cora N. Sternberg et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2024

"Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial" 

  • Author: Maha Hussain; Bertrand Tombal; Fred Saad; Karim Fizazi; Cora N. Sternberg; E. David Crawford; Neal Shore; Evgeny Kopyltsov; Arash Rezazadeh Kalebasty; Martin Bögemann et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2023